Daewoong Pharmaceuticals Co., Ltd pursues meaningful work by collaborating with great people, working with autonomy, and choosing opportunities that create shared value for the company, customers, and society. Above all, we are committed to driving real change and innovation through what we do. Establish in 1945, Daewoong Pharmaceuticals is a leading healthcare company in Korea that has achieved consecutive successes in new drug development through constant challenge and innovation. Today, we continue to expand a diverse pipeline and next-generation platform technologies, aiming to develop first-in-class and best-in-class innovative medicines for patients worldwide. Our commitment to global standards is proven by GMP certifications from major regulatory authorities such as the U.S. FDA and EMA, along with ISO certifications that demonstrate our excellence in quality, environmental management, and occupational health and safety systems. At Daewoong, we believe that the growth of our employees fuels the growth of the company. We foster a forward-looking corporate culture by promoting smart work practices, career development, and global talent training programs. Beyond Korea, we strive to become a global healthcare leader by creating new value for healthier lives and better quality of life worldwide.
Daewoong Pharmaceutical의 시장 확장을 추적하고 있습니다
최근 90일간 시그널 92건.
Daewoong Pharmaceutical의 글로벌 확장이 경쟁사와 비교해 어떤지
Daewoong Pharmaceutical본 회사막대는 비교 대상 회사 간 상대적 규모를 나타냅니다.
열5| 회사 | 시장 | 신규 시장 | 모멘텀 | 활동 | 확장 점수 |
|---|---|---|---|---|---|
 Daewoong Pharmaceutical본 회사 | 0 | 0 | — | 0 | 0 |
Senior Partnership & Leasing - Bali
공고 보기Kuta, Bali, Indonesia · 5개월 전
Chief Engineer - Bali
공고 보기Kuta, Bali, Indonesia · 5개월 전
Cafe Team
공고 보기Kuta, Bali, Indonesia · 6개월 전
#News 📢 대웅제약 presented integrated model-based research findings on its SGLT-2 inhibitor #Enavogliflozin, at the 2026 PAGE (PAGE - Population Approach Group Europe) conference, a leading European forum in quantitative pharmacology.This study quantitatively elucidated the causal relationship between increased urinary glucose excretion following drug administration and the reduction in glycated hemoglobin (HbA1c), and scientifically demonstrated that the absence of significant pharmacokinetic diff ...
종료됨Not all long-acting depot platforms are created equal. The key lies in how efficiently a drug can be delivered — in a smaller volume.In Episode 2 of the "Maximizing Therapeutic Potential with CURE®" series, we explore how CURE® achieves industry-leading drug loading to deliver a once-monthly therapeutic dose with up to 4–5× less depot mass than competing platforms.#Daewoong #GLP1 #CURE #platform #obesity #diseases #longactinginjectables ...
종료됨Small differences in wording can easily lead to misunderstandings in pharmaceutical communication.✍️👩💻Ji Young Yoon from 대웅제약’s Medical Team took on the challenge of bringing clarity to the confusion surrounding UDCA-related scientific messages, which had been spreading across multiple channels during the pandemic. By restructuring the messaging system, she helped ensure that accurate, evidence-based information could be delivered consistently.Curious about her journey? Watch the full video no ...
진행 중금융권 인사들이 대웅제약 오송 스마트 공장을 방문해 제약산업에서의 국민성장펀드 혁신 가능성을 모색했다.
대원제약이 멘토라이프 브랜드로 성인용 항산화제와 어린이용 면역 증강제 2종의 건강기능식품을 출시했습니다.
대웅제약, 올해 디지털 헬스케어 매출 3천억원 목표. 통합 AI 헬스케어 플랫폼 공개 및 전국민 원격 건강 모니터링 계획 발표.
인증된 이메일과 직통 전화 잠금 해제
무료 · 신용카드 불필요
Daewoong Pharmaceutical의 사업, 시장, 성장 시그널에 대한 빠른 답변입니다.
© 2026 Pubrio. 모든 권리 보유.
